Fed. Circ. Revives 5 Mylan Drug Patents In Sunovion Row
The Federal Circuit on Monday threw out a ruling that five Mylan Inc. patents covering treatments for chronic pulmonary obstructive disease were invalid, reviving claims that Sunovion Pharmaceuticals Inc.'s drug Brovana...To view the full article, register now.
Already a subscriber? Click here to view full article